Entering text into the input field will update the search result below

Ocuphire adds 24% as Viatris agrees to sell lead asset

Gratitude Concept With Heart Symbol

Eoneren

Ocuphire Pharma, Inc. (NASDAQ:OCUP), a company focused on eye disorders, jumped ~24% pre-market Tuesday after announcing that Viatris (NASDAQ:VTRS) has joined hands to commercialize its lead asset Nyxol once approved.

The transaction is part of an exclusive licensing deal Ocuphire (

Recommended For You

Related Stocks

SymbolLast Price% Chg
OCUP
--
VTRS
--